Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease

J. Chapuis, D. Hot, F. Hansmannel, O. Kerdraon, S. Ferreira, C. Hubans, C. A. Maurage, L. Huot, F. Bensemain, G. Laumet, A. M. Ayral, N. Fievet, J. J. Hauw, S. T. Dekosky, Y. Lemoine, T. Iwatsubo, F. Wavrant-Devrièze, J. F. Dartigues, C. Tzourio, L. BuéeF. Pasquier, C. Berr, D. Mann, C. Lendon, A. Alpérovitch, M. I. Kamboh, P. Amouyel, J. C. Lambert

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The only recognized genetic determinant of the common forms of Alzheimer's disease (AD) is the 4 allele of the apolipoprotein E gene (APOE). To identify new candidate genes, we recently performed transcriptomic analysis of 2741 genes in chromosomal regions of interest using brain tissue of AD cases and controls. From 82 differentially expressed genes, 1156 polymorphisms were genotyped in two independent discovery subsamples (n945). Seventeen genes exhibited at least one polymorphism associated with AD risk, and following correction for multiple testing, we retained the interleukin (IL)-33 gene. We first confirmed that the IL-33 expression was decreased in the brain of AD cases compared with that of controls. Further genetic analysis led us to select three polymorphisms within this gene, which we analyzed in three independent case-control studies. These polymorphisms and a resulting protective haplotype were systematically associated with AD risk in non-APOE 4 carriers. Using a large prospective study, these associations were also detected when analyzing the prevalent and incident AD cases together or the incident AD cases alone. These polymorphisms were also associated with less cerebral amyloid angiopathy (CAA) in the brain of non-APOE 4 AD cases. Immunohistochemistry experiments finally indicated that the IL-33 expression was consistently restricted to vascular capillaries in the brain. Moreover, IL-33 overexpression in cellular models led to a specific decrease in secretion of the AΒ 40 peptides, the main CAA component. In conclusion, our data suggest that genetic variants in IL-33 gene may be associated with a decrease in AD risk potentially in modulating CAA formation. © 2009 Nature Publishing Group All rights reserved.
    Original languageEnglish
    Pages (from-to)1004-1016
    Number of pages12
    JournalMolecular psychiatry
    Volume14
    Issue number11
    DOIs
    Publication statusPublished - Nov 2009

    Keywords

    • Alzheimer
    • Brain expression
    • CAA
    • IL-33
    • Polymorphism

    Fingerprint

    Dive into the research topics of 'Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this